Tilray | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Acasti Pharma USD -0.36 1.85M 2024-12
Alaunos Therapeutics USD 1.01M 17K 2024-09
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Avita Medical AUD 21.23M 2.57M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Cronos Group USD 20.68M 130K 2024-12
Dianthus Therapeutics USD 6.54M 530K 2024-09
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
IQVIA Holdings USD 453M 69M 2024-12
Knight Therapeutics CAD 25.48M 119K 2024-09
Moderna USD 351M 70M 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Organon & Co USD 470M 48M 2024-12
Revvity USD 255.62M 23.46M 2024-12
Tectonic Therapeutic USD 5.3M 962K 2024-09
Tilray USD 72.38M 4.99M 2024-11
Viatris USD 882.7M 14.8M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12



Tilray Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.